BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1979014)

  • 1. [Expression of P-glycoprotein 170 (GP 170) and drug resistance in human cancers].
    Bourhis J; Riou G; Bénard J
    Bull Cancer; 1990; 77(10):957-65. PubMed ID: 1979014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular targets in oncology: implications of the multidrug resistance gene.
    Lum BL; Gosland MP; Kaubisch S; Sikic BI
    Pharmacotherapy; 1993; 13(2):88-109. PubMed ID: 8097038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.
    Noonan KE; Beck C; Holzmayer TA; Chin JE; Wunder JS; Andrulis IL; Gazdar AF; Willman CL; Griffith B; Von Hoff DD; Roninson IB
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7160-4. PubMed ID: 1976252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cancers of the kidney: multiple drug resistance].
    Oudard S; Lizard G; Roignot P; Poupon MF
    Bull Cancer; 1993 Oct; 80(10):866-75. PubMed ID: 7911345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line.
    Baas F; Jongsma AP; Broxterman HJ; Arceci RJ; Housman D; Scheffer GL; Riethorst A; van Groenigen M; Nieuwint AW; Joenje H
    Cancer Res; 1990 Sep; 50(17):5392-8. PubMed ID: 1974823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of a multidrug resistance gene in human cancers.
    Goldstein LJ; Galski H; Fojo A; Willingham M; Lai SL; Gazdar A; Pirker R; Green A; Crist W; Brodeur GM
    J Natl Cancer Inst; 1989 Jan; 81(2):116-24. PubMed ID: 2562856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multiple drug resistance: a problem in cancer chemotherapy].
    Lizano Soberón M; Barrera Rodríquez R
    Rev Invest Clin; 1993; 45(5):481-92. PubMed ID: 7907810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-glycoproteins in pathology: the multidrug resistance gene family in humans.
    Weinstein RS; Kuszak JR; Kluskens LF; Coon JS
    Hum Pathol; 1990 Jan; 21(1):34-48. PubMed ID: 1967244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of multidrug resistance in cancer chemotherapy.
    Nooter K; Stoter G
    Pathol Res Pract; 1996 Jul; 192(7):768-80. PubMed ID: 8880878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug resistance genes].
    Marie JP
    Presse Med; 1992 Jun; 21(22):1033-7. PubMed ID: 1354869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the multidrug resistance gene in human tumors.
    Kim R
    Hiroshima J Med Sci; 1990 Sep; 39(3):71-7. PubMed ID: 1980915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multidrug resistance induced by surexpression of the mdrl gene].
    Guerci AP
    Rev Med Interne; 1993; 14(8):772-9. PubMed ID: 7910697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relationship between MDR1 gene and gallbladder cancer.
    Wang BL; Zhai HY; Chen BY; Zhai SP; Yang HY; Chen XP; Zhao WT; Meng L
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):296-9. PubMed ID: 15138130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists.
    Chaudhary PM; Roninson IB
    Oncol Res; 1992; 4(7):281-90. PubMed ID: 1360276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of multiple drug resistance in human cancers.
    Bénard J; Bourhis J; Riou G
    Anticancer Res; 1990; 10(5A):1297-302. PubMed ID: 1978633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel approaches to reversing anti-cancer drug resistance using gene-specific therapeutics.
    Kobayashi H; Takemura Y; Miyachi H
    Hum Cell; 2001 Sep; 14(3):172-84. PubMed ID: 11774737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistance gene expression in pediatric primitive neuroectodermal tumors of the central nervous system.
    Tishler DM; Weinberg KI; Sender LS; Nolta JA; Raffel C
    J Neurosurg; 1992 Mar; 76(3):507-12. PubMed ID: 1346632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of mdr1 gene expression in acute myeloid leukemia and comparison of different diagnostic methods.
    Zhou DC; Marie JP; Suberville AM; Zittoun R
    Leukemia; 1992 Sep; 6(9):879-85. PubMed ID: 1355575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-drug resistance genes in the management of neoplastic disease.
    Stewart J; Gorman NT
    J Vet Intern Med; 1991; 5(4):239-47. PubMed ID: 1682490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia.
    List AF; Spier C; Greer J; Wolff S; Hutter J; Dorr R; Salmon S; Futscher B; Baier M; Dalton W
    J Clin Oncol; 1993 Sep; 11(9):1652-60. PubMed ID: 8102639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.